IJTLD OPEN

Decentralising TB services for children: quality of care is fundamental
pp. 245-247(3)
Authors: Graham, S.M.; Zawedde-Muyanja, S.; Palmer, M.; Dlodlo, R.A.

Beyond a cure for TB: confronting the hidden burden of post-TB lung disease
pp. 248-250(3)
Authors: Kherabi, Y.; Silva, D.R.; Centis, R.; D’Ambrosio, L.; Migliori, G.B.

Assessing the impact of the TB response in Taiwan – the journey towards ending TB
pp. 251-259(9)
Authors: Chan, P.-C.; Chiang, C.-Y.; Lee, P.-H.; Lo, H.-Y.; Chu, P.-W.; Chen, J.-J.; Kato, S.; Raviglione, M.C.B.

Does nutritional support contribute to mitigating the financial burden faced by TB-affected households?
pp. 260-268(9)
Authors: Inthavong, D.; Elsayed, H.; Keonakhone, P.; Seevisay, V.; Souksanh, S.; Suthepmany, S.; Siphanthong, P.; Sengmany, P.; Sisounon, B.; Sebert, J.; Yanagawa, M.; Morishita, F.; Nishikiori, N.; Yamanaka, T.

Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB
pp. 269-275(7)
Authors: Zeng, C.; Hernán, M.A.; Trevisi, L.; Sauer, S.; Mitnick, C.D.; Hewison, C.; Bastard, M.; Khan, P.; Seung, K.J.; Rich, M.L.; Law, S.; Kikvidze, M.; Kirakosyan, O.; Miankou, A.; Thit, P.; Mamsa, S.; Janmohamed, A.; Melikyan, N.; Ahmed, S.; Vargas, D.; Binegdie, A.B.; Temirova, K.; Oyewusi, L.; Philippe, K.; Vilbrun, S.C.; Khan, U.; Huerga, H.; Franke, M.F.

Patient and provider preferences for long-acting TB preventive therapy
pp. 276-283(8)
Authors: Vermeulen, M.; Scarsi, K.K.; Furl, R.; Sayles, H.; Anderson, M.J.; Valawalkar, S.; Kadam, A.; Cox, S.R.; Mave, V.; Barthwal, M.; Schutz, C.; Ward, A.; Dountio Ofimboudem, J.; Meintjes, G.; Rannard, S.; Owen, A.; Swindells, S.

Treatment success rate and time to culture conversion under a prospective BPaL cohort study
pp. 284-290(7)
Authors: Burhan, E.; Sugiharto, J.; Soemarno, M.; Juan, A.; Runtu, Y.; Yuvensia, A.; Ramadhani, R.; Sabono, J.; Lailiyah, A.; Fenni, F.; Farikha, M.; Pakasi, T.; Pambudi, I.; Mbenga, M.; Koppelaar, I.; Mirtskhulava, V.; Wares, F.; Jerene, D.; Jung, J.K.; Lee, J.S.; Foraida, S.; Juneja, S.; Diachenko, M.; Gebhard, A.

TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
pp. 291-298(8)
Authors: Adakun, S.A.; Banda, F.M.; Bloom, A.; Bochnowicz, M.; Chakaya, J.; Chimzizi, R.; Dongo, J.P.; Duri, C.; Harries, A.D.; Kathure, I.; Kavenga, F.N.; Kumar, A.M.V.; Lin, Y.; Luzze, H.; Mbithi, I.; Mputu, M.; Mubanga, A.; Mudoola, D.; Nair, D.; Ngwenya, M.; Ntambi, S.; Owiti, P.; Owuor, A.; Thekkur, P.; Timire, C.; Tweyongyere, E.; YaDiul, M.; Zachariah, R.

Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up
pp. 299-305(7)
Authors: Sun, Y.; Lin, Y.; Golub, J.E.; Shu, W.; Jiang, J.; Xu, Q.; Li, Y.; Sun, W.; Shi, Y.; Liao, J.; Nie, C.; Liang, C.; Zhang, X.; Liu, H.; Ma, Y.; Zachariah, R.; Berger, S.D.; Thekkur, P.; Nair, D.; Satyanarayana, S.; Kumar, A.M.V.; Harries, A.D.

Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection
pp. 306-309(4)
Authors: Glover, N.A.; Paramo, L.; Giangregorio, S.; Sukwana, B.; Koele, S.E.; Charalambous, S.; Ngwanto, T.; Mashatole, S.; Mudzengi, D.; Heinrich, N.; Svensson, E.M.; Abdullah, F.; Churchyard, G.; Wallis, R.S.

Impact of autologous serum on an in vitro granuloma model to study the dynamics of Mycobacterium tuberculosis infection
pp. 310-313(4)
Authors: Bourg, C.; Hodille, E.; Ader, F.; Dumitrescu, O.; Genestet, C.